Latest Observability News

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.

Apollo Minerals reports exceptional drilling results at its Salanie Gold Project in Gabon, revealing high-grade gold mineralisation and securing $1.25 million through a recent entitlement offer.

Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.

RLG Ltd has successfully raised $900,000 through a two-tranche placement to fund the development of its food and health products and expand global sales channels. The second tranche, involving options issuance, awaits shareholder approval.

88 Energy Limited announces a maiden internal Prospective Resource estimate of 283 million barrels of oil for its Canning Prospect at Project Leonis, Alaska, with plans to drill the Tiri-1 exploration well targeting multiple reservoirs in 2026.

Alterity Therapeutics has announced encouraging Phase 2 trial results for ATH434, showing significant slowing of disease progression in multiple system atrophy (MSA) patients and a strong safety profile. These findings mark a potential breakthrough in treating a disease with no approved therapies.

Argenica Therapeutics has received a positive safety review from its independent DSMB for the Phase 2 trial of ARG-007 in acute ischaemic stroke patients, with dosing now 86% complete and full recruitment expected by early Q2 2025.

Southern Cross Gold Consolidated has reported exceptional high-grade gold intersections from deep drilling at its Christina prospect, confirming robust mineralization extending 350 metres below previous hits and expanding the Sunday Creek project's footprint.

Nickel Industries reveals a substantial Exploration Target of 350 to 700 million dry metric tonnes at 0.9% to 1.1% nickel for its Sampala Project, complementing an existing 187 million dmt resource. The company has initiated mine development and haul road construction, positioning itself for a secure nickel supply chain.

Barton Gold has confirmed significant high-grade silver alongside gold in its Tolmer gold system at the Tarcoola Project, prompting a new drilling campaign to explore the promising mineralisation further.

Heavy Rare Earths Limited (ASX:HRE) advanced its uranium exploration footprint in South Australia with a key asset acquisition and bolstered its balance sheet through a $2.46 million capital raise during the December 2024 quarter.

Biome Australia Limited has announced encouraging results from functional studies on its probiotic strain BMB18, highlighting its potential to modulate immune responses, reduce inflammation, and support intestinal health. These findings pave the way for targeted clinical research and product innovation.